A New Single-Cell Sequencing and Analysis Platform to Accelerate Cell and Gene Therapy Pipelines, Upcoming Webinar Hosted by Xtalks
Many of these therapies involve the genetic engineering of cells in order to insert exogenous sequences or alter existing genes.
- Many of these therapies involve the genetic engineering of cells in order to insert exogenous sequences or alter existing genes.
- After the cells are altered, they are introduced into the patient where they either replace dysfunctional cells or provide a desired immune response.
- For instance, there may be cell-to-cell variability in transduction efficiency and copy number (for viruses), or for on- and off-target editing efficiencies (for gene editors).
- Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.\nSydney Perelmutter, Xtalks, +1 (416) 977-6555 x 352, [email protected]\n'